<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-02-01" modified="2018-01-31" version="174">
<accession>P41279</accession>
<accession>A8K2Q5</accession>
<accession>D3DRX1</accession>
<accession>Q14275</accession>
<accession>Q5T855</accession>
<accession>Q9HC81</accession>
<name>M3K8_HUMAN</name>
<protein>
<recommendedName>
<fullName>Mitogen-activated protein kinase kinase kinase 8</fullName>
<ecNumber>2.7.11.25</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Cancer Osaka thyroid oncogene</fullName>
</alternativeName>
<alternativeName>
<fullName>Proto-oncogene c-Cot</fullName>
</alternativeName>
<alternativeName>
<fullName>Serine/threonine-protein kinase cot</fullName>
</alternativeName>
<alternativeName>
<fullName>Tumor progression locus 2</fullName>
<shortName>TPL-2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">MAP3K8</name>
<name type="synonym">COT</name>
<name type="synonym">ESTF</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="Mol. Cell. Biol." volume="11" first="4088" last="4096">
<title>Structure and transforming potential of the human cot oncogene encoding a putative protein kinase.</title>
<authorList>
<person name="Miyoshi J."/>
<person name="Higashi T."/>
<person name="Mukai H."/>
<person name="Ohuchi T."/>
<person name="Kakunaga T."/>
</authorList>
<dbReference type="PubMed" id="2072910"/>
<dbReference type="DOI" id="10.1128/MCB.11.8.4088"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>ONCOGENIC VARIANT</scope>
<source>
<tissue>Hepatoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="22723" last="22732">
<title>The human cot proto-oncogene encodes two protein serine/threonine kinases with different transforming activities by alternative initiation of translation.</title>
<authorList>
<person name="Aoki M."/>
<person name="Sugimoto T."/>
<person name="Sumida S."/>
<person name="Hamada F."/>
<person name="Akiyama T."/>
<person name="Toyoshima K."/>
</authorList>
<dbReference type="PubMed" id="8226782"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1993" name="Oncogene" volume="8" first="1329" last="1333">
<title>Expression cDNA cloning of a serine kinase transforming gene.</title>
<authorList>
<person name="Chan A.M."/>
<person name="Chedid M."/>
<person name="McGovern E.S."/>
<person name="Popescu N.C."/>
<person name="Miki T."/>
<person name="Aaronson S.A."/>
</authorList>
<dbReference type="PubMed" id="8479752"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Bone</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Tongue</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nature" volume="429" first="375" last="381">
<title>The DNA sequence and comparative analysis of human chromosome 10.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Earthrowl M.E."/>
<person name="Grafham D.V."/>
<person name="Rubenfield M."/>
<person name="French L."/>
<person name="Steward C.A."/>
<person name="Sims S.K."/>
<person name="Jones M.C."/>
<person name="Searle S."/>
<person name="Scott C."/>
<person name="Howe K."/>
<person name="Hunt S.E."/>
<person name="Andrews T.D."/>
<person name="Gilbert J.G.R."/>
<person name="Swarbreck D."/>
<person name="Ashurst J.L."/>
<person name="Taylor A."/>
<person name="Battles J."/>
<person name="Bird C.P."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ashwell R.I.S."/>
<person name="Ambrose K.D."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Cahill P."/>
<person name="Camire D."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Corby N."/>
<person name="Coulson A."/>
<person name="Dhami P."/>
<person name="Dutta I."/>
<person name="Dunn M."/>
<person name="Faulkner L."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Grocock R."/>
<person name="Gustafson E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E."/>
<person name="Heath P.D."/>
<person name="Ho T.P."/>
<person name="Hopkins B."/>
<person name="Horne J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hynds C."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Kana A."/>
<person name="Kay M."/>
<person name="Kimberley A.M."/>
<person name="Kershaw J.K."/>
<person name="Kokkinaki M."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lee H.M."/>
<person name="Leongamornlert D.A."/>
<person name="Laird G."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nguyen M."/>
<person name="Overton-Larty E."/>
<person name="Palmer S.A."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Porter K."/>
<person name="Rice C.M."/>
<person name="Rogosin A."/>
<person name="Ross M.T."/>
<person name="Sarafidou T."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Standring L."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Torcasso W."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tsolas J."/>
<person name="Wall M."/>
<person name="Walsh J."/>
<person name="Wang H."/>
<person name="Weinstock K."/>
<person name="West A.P."/>
<person name="Willey D.L."/>
<person name="Whitehead S.L."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Chen Y."/>
<person name="Lovering R.C."/>
<person name="Moschonas N.K."/>
<person name="Siebert R."/>
<person name="Fechtel K."/>
<person name="Bentley D."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Doucette-Stamm L."/>
<person name="Beck S."/>
<person name="Smith D.R."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="15164054"/>
<dbReference type="DOI" id="10.1038/nature02462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="31379" last="31386">
<title>COT kinase proto-oncogene expression in T cells: implication of the JNK/SAPK signal transduction pathway in COT promoter activation.</title>
<authorList>
<person name="Sanchez-Gongora E."/>
<person name="Lisbona C."/>
<person name="de Gregorio R."/>
<person name="Ballester A."/>
<person name="Calvo V."/>
<person name="Perez-Jurado L."/>
<person name="Alemany S."/>
</authorList>
<dbReference type="PubMed" id="10896655"/>
<dbReference type="DOI" id="10.1074/jbc.M000382200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-112</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1991" name="Oncogene" volume="6" first="1515" last="1519">
<title>Identification and characterization of protein products of the cot oncogene with serine kinase activity.</title>
<authorList>
<person name="Aoki M."/>
<person name="Akiyama T."/>
<person name="Miyoshi J."/>
<person name="Toyoshima K."/>
</authorList>
<dbReference type="PubMed" id="1833717"/>
</citation>
<scope>ALTERNATIVE INITIATION</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Nature" volume="397" first="363" last="368">
<title>TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.</title>
<authorList>
<person name="Belich M.P."/>
<person name="Salmeron A."/>
<person name="Johnston L.H."/>
<person name="Ley S.C."/>
</authorList>
<dbReference type="PubMed" id="9950430"/>
<dbReference type="DOI" id="10.1038/16946"/>
</citation>
<scope>INTERACTION WITH NFKB1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="J. Immunol." volume="166" first="6084" last="6090">
<title>p27kip protein levels and E2F activity are targets of Cot kinase during G1 phase progression in T cells.</title>
<authorList>
<person name="Velasco-Sampayo A."/>
<person name="Alemany S."/>
</authorList>
<dbReference type="PubMed" id="11342626"/>
<dbReference type="DOI" id="10.4049/jimmunol.166.10.6084"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="47089" last="47097">
<title>Identification of a novel human kinase supporter of Ras (hKSR-2) that functions as a negative regulator of Cot (Tpl2) signaling.</title>
<authorList>
<person name="Channavajhala P.L."/>
<person name="Wu L."/>
<person name="Cuozzo J.W."/>
<person name="Hall J.P."/>
<person name="Liu W."/>
<person name="Lin L.-L."/>
<person name="Zhang Y."/>
</authorList>
<dbReference type="PubMed" id="12975377"/>
<dbReference type="DOI" id="10.1074/jbc.M306002200"/>
</citation>
<scope>INTERACTION WITH KSR2</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Mol. Cell" volume="11" first="685" last="694">
<title>NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase.</title>
<authorList>
<person name="Waterfield M.R."/>
<person name="Zhang M."/>
<person name="Norman L.P."/>
<person name="Sun S.C."/>
</authorList>
<dbReference type="PubMed" id="12667451"/>
<dbReference type="DOI" id="10.1016/S1097-2765(03)00070-4"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NFKB1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="52117" last="52123">
<title>Phosphorylation of threonine 290 in the activation loop of Tpl2/Cot is necessary but not sufficient for kinase activity.</title>
<authorList>
<person name="Luciano B.S."/>
<person name="Hsu S."/>
<person name="Channavajhala P.L."/>
<person name="Lin L.L."/>
<person name="Cuozzo J.W."/>
</authorList>
<dbReference type="PubMed" id="15466476"/>
<dbReference type="DOI" id="10.1074/jbc.M403716200"/>
</citation>
<scope>PHOSPHORYLATION AT THR-290</scope>
<scope>INTERACTION WITH KSR2</scope>
<scope>MUTAGENESIS OF THR-290</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="5235" last="5248">
<title>ABIN-2 forms a ternary complex with TPL-2 and NF-kappa B1 p105 and is essential for TPL-2 protein stability.</title>
<authorList>
<person name="Lang V."/>
<person name="Symons A."/>
<person name="Watton S.J."/>
<person name="Janzen J."/>
<person name="Soneji Y."/>
<person name="Beinke S."/>
<person name="Howell S."/>
<person name="Ley S.C."/>
</authorList>
<dbReference type="PubMed" id="15169888"/>
<dbReference type="DOI" id="10.1128/MCB.24.12.5235-5248.2004"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NFKB1 AND TNIP2</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="2350" last="2355">
<title>Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide.</title>
<authorList>
<person name="Cho J."/>
<person name="Tsichlis P.N."/>
</authorList>
<dbReference type="PubMed" id="15699325"/>
<dbReference type="DOI" id="10.1073/pnas.0409856102"/>
</citation>
<scope>PHOSPHORYLATION AT THR-290</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="Cell. Signal." volume="18" first="1376" last="1385">
<title>TRAF6 and Src kinase activity regulates Cot activation by IL-1.</title>
<authorList>
<person name="Rodriguez C."/>
<person name="Pozo M."/>
<person name="Nieto E."/>
<person name="Fernandez M."/>
<person name="Alemany S."/>
</authorList>
<dbReference type="PubMed" id="16371247"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2005.10.016"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="2269" last="2276">
<title>Characterization of phosphorylation sites on Tpl2 using IMAC enrichment and a linear ion trap mass spectrometer.</title>
<authorList>
<person name="Black T.M."/>
<person name="Andrews C.L."/>
<person name="Kilili G."/>
<person name="Ivan M."/>
<person name="Tsichlis P.N."/>
<person name="Vouros P."/>
</authorList>
<dbReference type="PubMed" id="17472361"/>
<dbReference type="DOI" id="10.1021/pr0700293"/>
</citation>
<scope>PHOSPHORYLATION AT THR-80; SER-400 AND SER-443</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Exp. Med." volume="205" first="2803" last="2812">
<title>Tpl2 kinase regulates T cell interferon-gamma production and host resistance to Toxoplasma gondii.</title>
<authorList>
<person name="Watford W.T."/>
<person name="Hissong B.D."/>
<person name="Durant L.R."/>
<person name="Yamane H."/>
<person name="Muul L.M."/>
<person name="Kanno Y."/>
<person name="Tato C.M."/>
<person name="Ramos H.L."/>
<person name="Berger A.E."/>
<person name="Mielke L."/>
<person name="Pesu M."/>
<person name="Solomon B."/>
<person name="Frucht D.M."/>
<person name="Paul W.E."/>
<person name="Sher A."/>
<person name="Jankovic D."/>
<person name="Tsichlis P.N."/>
<person name="O'Shea J.J."/>
</authorList>
<dbReference type="PubMed" id="19001140"/>
<dbReference type="DOI" id="10.1084/jem.20081461"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Biochem. J." volume="424" first="109" last="118">
<title>IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2.</title>
<authorList>
<person name="Handoyo H."/>
<person name="Stafford M.J."/>
<person name="McManus E."/>
<person name="Baltzis D."/>
<person name="Peggie M."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="19754427"/>
<dbReference type="DOI" id="10.1042/BJ20091271"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-62; THR-290 AND SER-400</scope>
<scope>MUTAGENESIS OF SER-62; LYS-167; ASP-270; THR-290 AND SER-400</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Diabetes" volume="59" first="61" last="70">
<title>Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis.</title>
<authorList>
<person name="Jager J."/>
<person name="Gremeaux T."/>
<person name="Gonzalez T."/>
<person name="Bonnafous S."/>
<person name="Debard C."/>
<person name="Laville M."/>
<person name="Vidal H."/>
<person name="Tran A."/>
<person name="Gual P."/>
<person name="Le Marchand-Brustel Y."/>
<person name="Cormont M."/>
<person name="Tanti J.F."/>
</authorList>
<dbReference type="PubMed" id="19808894"/>
<dbReference type="DOI" id="10.2337/db09-0470"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="Mol. Cell. Biol." volume="32" first="4684" last="4690">
<title>IkappaB kinase 2 regulates TPL-2 activation of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400.</title>
<authorList>
<person name="Roget K."/>
<person name="Ben-Addi A."/>
<person name="Mambole-Dema A."/>
<person name="Gantke T."/>
<person name="Yang H.T."/>
<person name="Janzen J."/>
<person name="Morrice N."/>
<person name="Abbott D."/>
<person name="Ley S.C."/>
</authorList>
<dbReference type="PubMed" id="22988300"/>
<dbReference type="DOI" id="10.1128/MCB.01065-12"/>
</citation>
<scope>PHOSPHORYLATION AT SER-400</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-141</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-141</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<comment type="function">
<text evidence="8 9 11 14 16 17 18 19">Required for lipopolysaccharide (LPS)-induced, TLR4-mediated activation of the MAPK/ERK pathway in macrophages, thus being critical for production of the proinflammatory cytokine TNF-alpha (TNF) during immune responses. Involved in the regulation of T-helper cell differentiation and IFNG expression in T-cells. Involved in mediating host resistance to bacterial infection through negative regulation of type I interferon (IFN) production. In vitro, activates MAPK/ERK pathway in response to IL1 in an IRAK1-independent manner, leading to up-regulation of IL8 and CCL4. Transduces CD40 and TNFRSF1A signals that activate ERK in B-cells and macrophages, and thus may play a role in the regulation of immunoglobulin production. May also play a role in the transduction of TNF signals that activate JNK and NF-kappa-B in some cell types. In adipocytes, activates MAPK/ERK pathway in an IKBKB-dependent manner in response to IL1B and TNF, but not insulin, leading to induction of lipolysis. Plays a role in the cell cycle. Isoform 1 shows some transforming activity, although it is much weaker than that of the activated oncogenic variant.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="subunit">
<text evidence="9 10 11 12 22">Forms a ternary complex with NFKB1/p105 and TNIP2. Interacts with NFKB1; the interaction increases the stability of MAP3K8 but inhibits its MEK phosphorylation activity, whereas loss of interaction following LPS stimulation leads to its degradation. Interacts with CD40 and TRAF6; the interaction is required for ERK activation. Interacts with KSR2; the interaction inhibits ERK and NF-kappa-B activation.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354900"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354900"/>
<interactant intactId="EBI-300010">
<id>P19838</id>
<label>NFKB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354900"/>
<interactant intactId="EBI-307326">
<id>Q00653</id>
<label>NFKB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354900"/>
<interactant intactId="EBI-714158">
<id>Q13526</id>
<label>PIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-354900"/>
<interactant intactId="EBI-359372">
<id>Q8NFZ5</id>
<label>TNIP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="16 21">Cytoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative initiation"/>
<isoform>
<id>P41279-1</id>
<name>1</name>
<name>58 kDa</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P41279-2</id>
<name>2</name>
<name>52 kDa</name>
<sequence type="described" ref="VSP_018843"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Expressed in several normal tissues and human tumor-derived cell lines.</text>
</comment>
<comment type="developmental stage">
<text>Isoform 1 is activated specifically during the S and G2/M phases of the cell cycle.</text>
</comment>
<comment type="induction">
<text evidence="17 19">Up-regulated by IL12 in T-lymphocytes. Up-regulated in subcutaneous adipose tissue of obese individuals.</text>
</comment>
<comment type="PTM">
<text evidence="12 13 15 18 20">Autophosphorylated. Isoform 1 undergoes phosphorylation mainly on Ser residues, and isoform 2 on both Ser and Thr residues. Thr-290 is autophosphorylated (PubMed:19754427) and/or transphosphorylated (PubMed:15466476); the phosphorylation is necessary but not sufficient for full kinase activity in vitro and for the dissociation of isoform 1 from NFKB1, leading to its degradation. Ser-400 is autophosphorylated (PubMed:19754427) and/or transphosphorylated by IKBKB (PubMed:22988300); the phosphorylation is required for LPS-stimulated activation of the MAPK/ERK pathway in macrophages.</text>
</comment>
<comment type="miscellaneous">
<text>Can be converted to an oncogenic protein by proviral activation, leading to a C-terminally truncated protein with transforming activity.</text>
</comment>
<comment type="similarity">
<text evidence="24">Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase kinase subfamily.</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/map3k8/"/>
</comment>
<dbReference type="EC" id="2.7.11.25"/>
<dbReference type="EMBL" id="D14497">
<property type="protein sequence ID" value="BAA03387.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z14138">
<property type="protein sequence ID" value="CAA78512.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290320">
<property type="protein sequence ID" value="BAF83009.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY309013">
<property type="protein sequence ID" value="AAP45053.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL161651">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW86004.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW86005.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW86006.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471072">
<property type="protein sequence ID" value="EAW86007.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC104833">
<property type="protein sequence ID" value="AAI04834.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113566">
<property type="protein sequence ID" value="AAI13567.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF133211">
<property type="protein sequence ID" value="AAG13454.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS7166.1">
<molecule id="P41279-1"/>
</dbReference>
<dbReference type="PIR" id="A48713">
<property type="entry name" value="A48713"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001231063.1">
<molecule id="P41279-1"/>
<property type="nucleotide sequence ID" value="NM_001244134.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307890.1">
<molecule id="P41279-1"/>
<property type="nucleotide sequence ID" value="NM_001320961.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005195.2">
<molecule id="P41279-1"/>
<property type="nucleotide sequence ID" value="NM_005204.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016871196.1">
<molecule id="P41279-1"/>
<property type="nucleotide sequence ID" value="XM_017015707.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016871197.1">
<molecule id="P41279-1"/>
<property type="nucleotide sequence ID" value="XM_017015708.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016871198.1">
<molecule id="P41279-1"/>
<property type="nucleotide sequence ID" value="XM_017015709.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016871199.1">
<molecule id="P41279-1"/>
<property type="nucleotide sequence ID" value="XM_017015710.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.432453"/>
<dbReference type="UniGene" id="Hs.663033"/>
<dbReference type="UniGene" id="Hs.731448"/>
<dbReference type="PDB" id="4Y83">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.89"/>
<property type="chains" value="A/B/C=66-395"/>
</dbReference>
<dbReference type="PDB" id="4Y85">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.33"/>
<property type="chains" value="A/B/C=66-395"/>
</dbReference>
<dbReference type="PDB" id="5IU2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=66-395"/>
</dbReference>
<dbReference type="PDBsum" id="4Y83"/>
<dbReference type="PDBsum" id="4Y85"/>
<dbReference type="PDBsum" id="5IU2"/>
<dbReference type="ProteinModelPortal" id="P41279"/>
<dbReference type="SMR" id="P41279"/>
<dbReference type="BioGrid" id="107719">
<property type="interactions" value="21"/>
</dbReference>
<dbReference type="CORUM" id="P41279"/>
<dbReference type="DIP" id="DIP-27534N"/>
<dbReference type="IntAct" id="P41279">
<property type="interactions" value="14"/>
</dbReference>
<dbReference type="MINT" id="MINT-1140505"/>
<dbReference type="STRING" id="9606.ENSP00000263056"/>
<dbReference type="BindingDB" id="P41279"/>
<dbReference type="ChEMBL" id="CHEMBL4899"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2083"/>
<dbReference type="iPTMnet" id="P41279"/>
<dbReference type="PhosphoSitePlus" id="P41279"/>
<dbReference type="BioMuta" id="MAP3K8"/>
<dbReference type="DMDM" id="50403742"/>
<dbReference type="MaxQB" id="P41279"/>
<dbReference type="PaxDb" id="P41279"/>
<dbReference type="PeptideAtlas" id="P41279"/>
<dbReference type="PRIDE" id="P41279"/>
<dbReference type="DNASU" id="1326"/>
<dbReference type="Ensembl" id="ENST00000263056">
<molecule id="P41279-1"/>
<property type="protein sequence ID" value="ENSP00000263056"/>
<property type="gene ID" value="ENSG00000107968"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000375321">
<molecule id="P41279-1"/>
<property type="protein sequence ID" value="ENSP00000364470"/>
<property type="gene ID" value="ENSG00000107968"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000542547">
<molecule id="P41279-1"/>
<property type="protein sequence ID" value="ENSP00000443610"/>
<property type="gene ID" value="ENSG00000107968"/>
</dbReference>
<dbReference type="GeneID" id="1326"/>
<dbReference type="KEGG" id="hsa:1326"/>
<dbReference type="UCSC" id="uc001ivi.3">
<molecule id="P41279-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1326"/>
<dbReference type="DisGeNET" id="1326"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000107968.9"/>
<dbReference type="GeneCards" id="MAP3K8"/>
<dbReference type="HGNC" id="HGNC:6860">
<property type="gene designation" value="MAP3K8"/>
</dbReference>
<dbReference type="HPA" id="CAB005120"/>
<dbReference type="HPA" id="HPA017962"/>
<dbReference type="MalaCards" id="MAP3K8"/>
<dbReference type="MIM" id="191195">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P41279"/>
<dbReference type="OpenTargets" id="ENSG00000107968"/>
<dbReference type="PharmGKB" id="PA30606"/>
<dbReference type="eggNOG" id="KOG0201">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XP9G">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00800000124036"/>
<dbReference type="HOGENOM" id="HOG000285978"/>
<dbReference type="HOVERGEN" id="HBG006306"/>
<dbReference type="InParanoid" id="P41279"/>
<dbReference type="KO" id="K04415"/>
<dbReference type="OMA" id="DVLLFPW"/>
<dbReference type="OrthoDB" id="EOG091G0682"/>
<dbReference type="PhylomeDB" id="P41279"/>
<dbReference type="TreeFam" id="TF105117"/>
<dbReference type="Reactome" id="R-HSA-389357">
<property type="pathway name" value="CD28 dependent PI3K/Akt signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5684264">
<property type="pathway name" value="MAP3K8 (TPL2)-dependent MAPK1/3 activation"/>
</dbReference>
<dbReference type="SignaLink" id="P41279"/>
<dbReference type="SIGNOR" id="P41279"/>
<dbReference type="ChiTaRS" id="MAP3K8">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="MAP3K8"/>
<dbReference type="GenomeRNAi" id="1326"/>
<dbReference type="PRO" id="PR:P41279"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 10"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000107968"/>
<dbReference type="CleanEx" id="HS_MAP3K8"/>
<dbReference type="ExpressionAtlas" id="P41279">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P41279">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0004709">
<property type="term" value="F:MAP kinase kinase kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0032147">
<property type="term" value="P:activation of protein kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007346">
<property type="term" value="P:regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0023014">
<property type="term" value="P:signal transduction by protein phosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051403">
<property type="term" value="P:stress-activated MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031098">
<property type="term" value="P:stress-activated protein kinase signaling cascade"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031295">
<property type="term" value="P:T cell costimulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR017424">
<property type="entry name" value="MAPKKK8"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF038171">
<property type="entry name" value="MAPKKK8"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Mitogen-activated protein kinase kinase kinase 8" id="PRO_0000024350">
<location>
<begin position="1"/>
<end position="467"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="6">
<location>
<begin position="138"/>
<end position="388"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="6">
<location>
<begin position="144"/>
<end position="152"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="6 7">
<location>
<position position="253"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="6">
<location>
<position position="167"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="18">
<location>
<position position="62"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15">
<location>
<position position="80"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5">
<location>
<position position="141"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12 13 18">
<location>
<position position="290"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15 18 20">
<location>
<position position="400"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="443"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_018843" evidence="23">
<location>
<begin position="1"/>
<end position="29"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3087944." id="VAR_051638">
<original>S</original>
<variation>F</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence variant" description="In oncogenic form." id="VAR_006198">
<original>CQSLDSALLERKRLLSRK</original>
<variation>GHQVIHEGSSTNDPNNSC</variation>
<location>
<begin position="398"/>
<end position="415"/>
</location>
</feature>
<feature type="sequence variant" description="In oncogenic form." id="VAR_006199">
<location>
<begin position="416"/>
<end position="467"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased IL1-stimulated activity. Loss of IL1-stimulated phosphorylation of T-290 and MEK phosphorylation activity; when associated with A-400." evidence="18">
<original>S</original>
<variation>A</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of catalytic activity." evidence="18">
<original>K</original>
<variation>R</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of catalytic activity." evidence="18">
<original>D</original>
<variation>A</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of MEK phosphorylation activity and almost abolished autophosphorylation activity. Loss of IL1-stimulated MEK phosphorylation activity but not of IL1-stimulated autophosphorylation activity. No effect on KSR2 binding." evidence="12 18">
<original>T</original>
<variation>A</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired MEK phosphorylation and autophosphorylation activities. No effect on KSR2 binding." evidence="12 18">
<original>T</original>
<variation>D</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of MEK phosphorylation activity and almost abolished autophosphorylation activity. No effect on KSR2 binding." evidence="12 18">
<original>T</original>
<variation>E</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly decreased IL1-stimulated MEK phosphorylation activity. Loss of IL1-stimulated phosphorylation of T-290 and MEK phosphorylation activity; when associated with A-62." evidence="18">
<original>S</original>
<variation>A</variation>
<location>
<position position="400"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; BAA03387 and 2; no nucleotide entry." ref="1 2" evidence="24">
<original>Q</original>
<variation>T</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="75"/>
<end position="78"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="81"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="106"/>
<end position="109"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="117"/>
<end position="119"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="124"/>
<end position="126"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="127"/>
<end position="130"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="135"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="138"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="148"/>
<end position="157"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="158"/>
<end position="160"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="163"/>
<end position="170"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="171"/>
<end position="173"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="177"/>
<end position="184"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="193"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="202"/>
<end position="207"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="215"/>
<end position="222"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="227"/>
<end position="246"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="256"/>
<end position="258"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="259"/>
<end position="261"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="266"/>
<end position="268"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="278"/>
<end position="282"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="291"/>
<end position="293"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="296"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="307"/>
<end position="322"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="326"/>
<end position="330"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="340"/>
<end position="346"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="350"/>
<end position="352"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="355"/>
<end position="357"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="359"/>
<end position="368"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="373"/>
<end position="375"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="379"/>
<end position="382"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="386"/>
<end position="388"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4Y83"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4Y85"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IU2"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11342626"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12667451"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12975377"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15169888"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15466476"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15699325"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16371247"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17472361"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1833717"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19001140"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19754427"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19808894"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22988300"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8226782"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9950430"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8226782"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000305"/>
<sequence length="467" mass="52925" checksum="7728969EA3E4E8EC" modified="2004-07-19" version="2">
MEYMSTGSDNKEEIDLLIKHLNVSDVIDIMENLYASEEPAVYEPSLMTMCQDSNQNDERS
KSLLLSGQEVPWLSSVRYGTVEDLLAFANHISNTAKHFYGQRPQESGILLNMVITPQNGR
YQIDSDVLLIPWKLTYRNIGSDFIPRGAFGKVYLAQDIKTKKRMACKLIPVDQFKPSDVE
IQACFRHENIAELYGAVLWGETVHLFMEAGEGGSVLEKLESCGPMREFEIIWVTKHVLKG
LDFLHSKKVIHHDIKPSNIVFMSTKAVLVDFGLSVQMTEDVYFPKDLRGTEIYMSPEVIL
CRGHSTKADIYSLGATLIHMQTGTPPWVKRYPRSAYPSYLYIIHKQAPPLEDIADDCSPG
MRELIEASLERNPNHRPRAADLLKHEALNPPREDQPRCQSLDSALLERKRLLSRKELELP
ENIADSSCTGSTEESEMLKRQRSLYIDLGALAGYFNLVRGPPTLEYG
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>